What is the recommended dose of Colimex (antibiotic) drops for a 3.5 kg newborn baby?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colimex Drops Dosing Information Not Available in Provided Evidence

I cannot provide a specific dosing recommendation for "Colimex drops" for a 3.5 kg baby because none of the provided evidence contains information about a product called "Colimex drops."

Important Clarification Needed

The term "Colimex" does not appear in any of the guideline or research evidence provided. However, the evidence does contain extensive information about colistin (polymyxin E), which is phonetically similar. I must clarify what medication is actually being requested:

If This is Colistin (Antibiotic):

For a 3.5 kg neonate requiring IV colistin for multidrug-resistant gram-negative infections, the dose would be 2.5-5 mg colistin base activity (CBA)/kg/day IV divided into 2 or 4 doses 1.

  • For a 3.5 kg infant, this calculates to 8.75-17.5 mg CBA per day total, divided into 2-4 doses 1
  • This would be approximately 4.4-8.75 mg CBA per dose if given twice daily 1
  • Maximum single dose is 100 mg CBA 1

Critical safety considerations for colistin in neonates:

  • Colistin has significant nephrotoxicity risk, particularly in critically ill patients 2
  • Renal function must be monitored closely 2
  • Colistin should only be used for confirmed multidrug-resistant gram-negative infections when no other options exist 3, 4
  • Oral colistin is NOT recommended for neonates as it can lead to colistin-resistant intestinal flora 5

If This is NOT Colistin:

You must verify the exact product name and active ingredient. "Colimex" may be:

  • A brand name for simethicone/dicyclomine (for infant colic)
  • A regional brand name for another medication
  • A compounded preparation

Without knowing the actual medication and its active ingredients, I cannot provide safe dosing guidance for this 3.5 kg infant.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2013

Research

Colistin: re-emergence of the 'forgotten' antimicrobial agent.

Journal of postgraduate medicine, 2013

Research

Colistin in the 21st century.

Current opinion in infectious diseases, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.